Market Tracker

09/29 5:16pm ET

Impax Laboratories Inc (NASDAQ:IPXL)

23.59
Delayed Data
As of Sep 29
 -1.14 / -4.61%
Today’s Change
20.97
Today|||52-Week Range
45.00
-44.83%
Year-to-Date
No recent news for Impax Laboratories Inc.

Today’s Trading

Previous close24.73
Today’s open24.79
Day’s range23.20 - 24.94
Volume1,170,856
Average volume (3 months)891,255
Market cap$1.8B
Dividend yield--
Data as of 3:59pm ET, 09/29/2016

Growth & Valuation

Earnings growth (last year)-33.33%
Earnings growth (this year)+9.81%
Earnings growth (next 5 years)+19.19%
Revenue growth (last year)+44.36%
P/E ratio49.1
Price/Sales3.58
Price/Book1.69

Competitors

 Today’s
change
Today’s
% change
ITCIIntra-Cellular Thera...-26.93-63.59%
LXRXLexicon Pharmaceutic...-0.16-0.89%
TBPHTheravance Biopharma...-1.73-4.69%
SAGESAGE Therapeutics In...-1.25-2.67%
Data as of 3:59pm ET, 09/29/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$0.39
Annual revenue (last year)$860.5M
Annual profit (last year)$39.0M
Net profit margin4.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts